Business Description
Core Laboratories Inc
NAICS : 213112
SIC : 3533
ISIN : NL0000200384
Share Class Description:
FRA:HJ1: Ordinary SharesDescription
Core Laboratories is the premier provider of reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.78 | |||||
| Debt-to-EBITDA | 2.63 | |||||
| Interest Coverage | 4 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.19 | |||||
| Beneish M-Score | -2.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.7 | |||||
| 3-Year EPS without NRI Growth Rate | 166.1 | |||||
| 3-Year FCF Growth Rate | -33.6 | |||||
| 3-Year Book Growth Rate | 44.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 10.58 | |||||
| Future 3-5Y Total Revenue Growth Rate | 3.98 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 10.04 | |||||
| 9-Day RSI | 20.17 | |||||
| 14-Day RSI | 28.65 | |||||
| 6-1 Month Momentum % | 12.94 | |||||
| 12-1 Month Momentum % | 14.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.48 | |||||
| Quick Ratio | 1.79 | |||||
| Cash Ratio | 0.23 | |||||
| Days Inventory | 59.76 | |||||
| Days Sales Outstanding | 78.43 | |||||
| Days Payable | 28.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.23 | |||||
| Dividend Payout Ratio | 0.06 | |||||
| 3-Year Dividend Growth Rate | -47.7 | |||||
| Forward Dividend Yield % | 0.24 | |||||
| 3-Year Average Share Buyback Ratio | -1.7 | |||||
| Shareholder Yield % | 3.62 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 17.56 | |||||
| Operating Margin % | 10.22 | |||||
| Net Margin % | 5.01 | |||||
| FCF Margin % | 8.42 | |||||
| ROE % | 11.17 | |||||
| ROA % | 4.42 | |||||
| ROIC % | 6.22 | |||||
| ROC (Joel Greenblatt) % | 21.72 | |||||
| ROCE % | 11.72 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 30.67 | |||||
| Forward PE Ratio | 17.74 | |||||
| PE Ratio without NRI | 23.85 | |||||
| Shiller PE Ratio | 11.62 | |||||
| Price-to-Owner-Earnings | 19.03 | |||||
| PS Ratio | 1.54 | |||||
| PB Ratio | 3.15 | |||||
| Price-to-Tangible-Book | 5.44 | |||||
| Price-to-Free-Cash-Flow | 18.24 | |||||
| Price-to-Operating-Cash-Flow | 14.54 | |||||
| EV-to-EBIT | 16.55 | |||||
| EV-to-Forward-EBIT | 13.71 | |||||
| EV-to-EBITDA | 13.16 | |||||
| EV-to-Forward-EBITDA | 11.33 | |||||
| EV-to-Revenue | 1.87 | |||||
| EV-to-Forward-Revenue | 1.66 | |||||
| EV-to-FCF | 22.06 | |||||
| Price-to-Projected-FCF | 1.41 | |||||
| Price-to-Median-PS-Value | 0.48 | |||||
| Price-to-Graham-Number | 2.41 | |||||
| Earnings Yield (Greenblatt) % | 6.05 | |||||
| FCF Yield % | 5.53 | |||||
| Forward Rate of Return (Yacktman) % | 0.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Core Laboratories Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 479.233 | ||
| EPS (TTM) (€) | 0.502 | ||
| Beta | 1.37 | ||
| Volatility % | 43.12 | ||
| 14-Day RSI | 28.65 | ||
| 14-Day ATR (€) | 0.476233 | ||
| 20-Day SMA (€) | 18.715 | ||
| 12-1 Month Momentum % | 14.7 | ||
| 52-Week Range (€) | 12.3 - 22.6 | ||
| Shares Outstanding (Mil) | 46.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Core Laboratories Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Core Laboratories Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Core Laboratories Inc Frequently Asked Questions
What is Core Laboratories Inc(FRA:HJ1)'s stock price today?
The current price of FRA:HJ1 is €16.00. The 52 week high of FRA:HJ1 is €22.60 and 52 week low is €12.30.
When is next earnings date of Core Laboratories Inc(FRA:HJ1)?
The next earnings date of Core Laboratories Inc(FRA:HJ1) is .
Does Core Laboratories Inc(FRA:HJ1) pay dividends? If so, how much?
The Dividend Yield %  of Core Laboratories Inc(FRA:HJ1) is 0.23% (As of Today), Highest Dividend Payout Ratio of Core Laboratories Inc(FRA:HJ1) was 6.51. The lowest was 0.05. And the median was 0.84. The  Forward Dividend Yield % of Core Laboratories Inc(FRA:HJ1) is 0.24%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers